Health-Related Quality of Life with Pembrolizumab in Patients with Locally Advanced or Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: KEYNOTE-629

• Main Authors: Åse Bratland (Author), Eva Munoz-Couselo (Author), Laurent Mortier (Author), Osama Roshdy (Author), Rene González (Author), Jacob Schachter (Author), Ana M. Arance (Author), Florent Grange (Author), Nicolas Meyer (Author), Abhishek Jagdish Joshi (Author), Salem Billan (Author), Brett G. M. Hughes (Author), Jean-Jacques Grob (Author), Karthik Ramakrishnan (Author), Joy Ge (Author), Burak Gumuscu (Author), Ramona F. Swaby (Author), Ralf Gutzmer (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2023-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Introduction At first interim analysis of KEYNOTE-629, health-related quality of life (HRQoL) with pembrolizumab was stable or improved over 48 weeks in recurrent or metastatic (R/M) cutaneous squamous cell carcinoma (cSCC). HRQoL results from the second interim analysis in R/M or locally a...